CIDI (03881.HK) Sets 30 Mar 2026 Board Meeting to Approve FY2025 Results

Bulletin Express
03/13

CiDi Inc. (CIDI, stock code 03881.HK) announced that its board of directors will convene on 30 March 2026 to review and approve the Group’s audited financial results for the year ended 31 December 2025 and to authorize their publication.

The notice, dated 13 March 2026, states that additional routine matters may also be addressed during the session.

Board composition at the time of the announcement is as follows: • Executive Directors: Dr. Ma Wei and Dr. Albert S. Hu (also Chief Executive Officer) • Non-Executive Directors: Prof. Li Zexiang, Ms. Yang Xi and Dr. Li Zhiyong • Independent Non-Executive Directors: Dr. Li Xiaoyuan, Prof. Tan Guangrong and Mr. Zhang Jiangang

The company did not disclose any financial figures in this notice; those details are expected upon release of the FY2025 results after board approval.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10